Last Update 04 Dec 25

Fair value Increased 4.01%

ALB: Future Returns Will Hinge On Sustained Lithium Price Recovery

Analysts have nudged our Albemarle fair value estimate higher to approximately $107 from about $103 per share, reflecting modestly improved lithium price expectations and slightly stronger long term earnings power despite still limited perceived upside.

Analyst Commentary

Street research has broadly shifted in a more constructive direction on Albemarle, with a series of target price increases reflecting higher assumed lithium prices and improved earnings power. However, the tone remains balanced, with many observers emphasizing that recent share appreciation already discounts a substantial portion of the medium term recovery.

Bullish Takeaways

Bullish analysts are lifting target prices as they raise medium term EBITDA forecasts, primarily on the back of stronger expected lithium pricing and a faster return to mid cycle conditions.
Expectations for the Energy Storage segment are improving, with some models now assuming higher average selling prices and an earlier realization of mid cycle price levels, which supports a higher intrinsic value for the franchise.
Some research highlights Albemarle’s spodumene exposure and relatively limited sensitivity to high Chilean royalties as key drivers of above peer earnings growth potential and improved capital returns over time.
Analysts see scope for further upside if execution on self help initiatives remains solid and if inflection point visibility in volumes and pricing continues to improve, which could justify multiples closer to historical norms.

Bearish Takeaways

Bearish analysts, despite increasing price targets, characterize the stock as fairly valued, arguing that the current share price already embeds much of the near term improvement in lithium prices and earnings revisions.
There is persistent caution that lithium market fundamentals still need to tighten further to sustain prices above reinvestment levels, limiting confidence in a durable re rating of the equity.
Several neutral views emphasize that upside is constrained by macro uncertainty around Chinese demand and policy, which could delay or dampen the expected recovery trajectory embedded in more optimistic models.
Some commentary stresses that while free cash flow generation has improved, the company still needs to demonstrate consistent execution on growth projects and capital allocation before investors are willing to reward the stock with a meaningfully higher valuation multiple.

What's in the News

Recorded a Goodwill impairment charge of approximately $181 million in the third quarter of 2025, signaling a reset of balance sheet carrying values in response to market conditions (Key Developments).
Issued 2025 earnings guidance calling for net sales between $4.9 billion and $5.2 billion, anchored to observed first half 2025 average market prices, providing investors with updated visibility on revenue expectations (Key Developments).

Valuation Changes

Fair Value Estimate has risen slightly to approximately $107 per share from about $103, reflecting a modestly more optimistic long term outlook.
Discount Rate has fallen marginally to roughly 7.81 percent from about 7.83 percent, indicating a slightly lower assumed cost of capital.
Revenue Growth has edged down slightly to around 10.46 percent from approximately 10.52 percent, implying a modestly more conservative top line trajectory.
Net Profit Margin has increased very slightly to about 5.05 percent from roughly 5.04 percent, signaling a minor improvement in expected profitability.
Future P/E has risen moderately to roughly 47.1x from about 45.3x, suggesting a somewhat higher valuation multiple applied to forward earnings.

Aggressive cost-cutting, productivity initiatives, and disciplined capital spending are boosting efficiency, cash flow, and financial flexibility amid volatile lithium prices.
Long-term contracts and policy support increase revenue stability and position Albemarle for premium pricing and future growth in key global markets.
Prolonged lithium price weakness, industry oversupply, regulatory uncertainty, and aggressive cost-cutting threaten Albemarle's growth, pricing power, and long-term competitive advantage.

Catalysts

About Albemarle

Provides energy storage solutions worldwide.What are the underlying business or industry changes driving this perspective?

Despite recent lithium price weakness, Albemarle is benefitting from exceptional global growth in lithium demand (up ~35% year-to-date), especially from accelerating EV adoption in China and Europe and surging stationary energy storage, supporting continued top-line revenue growth as supply and demand rebalance.
The company is executing aggressive cost reduction and productivity initiatives (achieving a $400M annual run-rate in savings, 6 months ahead of plan), ramping low-cost asset expansions, and optimizing its conversion network, which is likely to structurally reduce operating costs and increase net margins in a lower price environment.
Albemarle's disciplined capital spending (60% CapEx reduction YoY and ongoing prioritization of highest-return projects) and improved cash conversion is enabling it to generate positive free cash flow, strengthen its balance sheet, and provide greater financial flexibility for future growth, which can bolster earnings as demand recovers and pricing normalizes.
With ~50% of sales volumes locked under long-term agreements with major Western OEM and battery customers, Albemarle benefits from enhanced revenue stability and reduced cyclicality, while maintaining pricing floors, partially insulating earnings from volatile spot prices and unfavorable market swings.
Secular policy tailwinds, such as the US Inflation Reduction Act and EU emissions targets, are incentivizing domestic lithium sourcing and battery production, potentially allowing Albemarle to command premium pricing, expand market share through its US and Chilean assets, and lock in future revenue growth as sustainability and supply chain localization accelerate.

Albemarle Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Albemarle's revenue will grow by 11.5% annually over the next 3 years.
Analysts assume that profit margins will increase from -22.0% today to 15.4% in 3 years time.
Analysts expect earnings to reach $1.1 billion (and earnings per share of $9.09) by about September 2028, up from $-1.1 billion today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as $-165.3 million.
In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 11.9x on those 2028 earnings, up from -8.6x today. This future PE is lower than the current PE for the US Chemicals industry at 25.7x.
Analysts expect the number of shares outstanding to grow by 0.12% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 8.04%, as per the Simply Wall St company report.

Albemarle Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?

Prolonged low lithium market pricing (around $9/kg LCE) has resulted in declining year-over-year sales and EBITDA, and if low pricing persists, it could continue to suppress Albemarle's top-line revenue growth and constrain net margins and earnings, especially as nearly half of sales remain exposed to volatile spot markets beyond 2025.
The lithium industry is currently in a state of oversupply and excess conversion capacity (notably, Chinese hard rock conversion operating at 50%), with potential for overcapacity to persist for years; this raises the risk of continued price volatility and market commoditization that could further erode Albemarle's pricing power, thereby reducing long-term earnings and operating margins.
Albemarle's aggressive cost-cutting, CapEx reductions, and focus on short-term financial flexibility may limit future volume growth once existing capacity expansions are exhausted; over time, this could lead to underinvestment, stagnating revenues, and loss of competitive advantage in the face of rising industry demand and new supply entering the market.
Uncertainty in global EV demand growth, particularly owing to regional policy changes (e.g., US tariff/federal incentive uncertainty, evolving European and Chinese subsidies), as well as the potential impact of alternative battery chemistries or increased lithium recycling, could dampen long-term demand for newly mined lithium and reduce Albemarle's revenue base.
Elevated geopolitical and regulatory risk-including resource nationalism in key supply regions (Chile, China), heightened environmental scrutiny over extraction methods, and possible permitting setbacks-may disrupt operations, increase compliance and operating costs, or curtail expansion plans, which would negatively impact long-term cash flows and profitability.

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $85.467 for Albemarle based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $200.0, and the most bearish reporting a price target of just $58.0.
In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $6.9 billion, earnings will come to $1.1 billion, and it would be trading on a PE ratio of 11.9x, assuming you use a discount rate of 8.0%.
Given the current share price of $80.11, the analyst price target of $85.47 is 6.3% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Albemarle?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Analysts Adjust Targets for Albemarle Amid Lithium Market Shifts and Safety Incident in Chile